Firms focused on drug discovery, genetic research, and life sciences.
Theme Performance
Equal-weight basket of constituents
1 Day
+0.11%
1 Week
+2.32%
1 Month
+3.76%
3 Months
+3.27%
Year to Date
+10.25%
Constituents
15 active symbols
| Ticker | Company | Market Cap | Price | 1D % | 1W % | 1M % | 3M % | YTD % |
|---|---|---|---|---|---|---|---|---|
| Amgen Inc | $177.979B | $336.2900 | -0.64% | +1.77% | -6.11% | -12.30% | +0.60% | |
| Gilead Sciences Inc | $165.774B | $134.9400 | +1.67% | +0.63% | -3.94% | -11.97% | +9.80% | |
| Vertex Pharmaceuticals Inc | $110.449B | $448.2900 | +1.24% | +1.24% | -0.25% | -7.58% | -3.75% | |
| Regeneron Pharmaceuticals Inc | $78.943B | $723.4100 | -0.30% | +0.50% | -4.82% | -8.65% | -8.18% | |
|
A
ARGX
|
argenx SE American Depositary Shares | $50.576B | $812.8100 | +3.98% | +0.27% | +1.70% | -1.81% | -3.18% |
| Alnylam Pharmaceuticals, Inc. | $38.030B | $292.0300 | -3.46% | -4.39% | -11.57% | -10.99% | -28.82% | |
| Biogen Inc. Common Stock | $29.225B | $199.3600 | +2.33% | +5.74% | +14.44% | +2.14% | +11.32% | |
|
B
BNTX
|
BioNTech SE American Depositary Share | $23.604B | $93.6600 | -0.83% | -6.05% | -2.26% | -15.41% | -3.46% |
| Illumina Inc | $21.562B | $145.7000 | +0.44% | +2.25% | +17.85% | +21.54% | +6.07% | |
| Incyte Genomics Inc | $20.042B | $99.1300 | +1.79% | +3.27% | +4.42% | -7.99% | -1.08% | |
| Moderna, Inc. Common Stock | $17.700B | $53.2700 | -2.70% | +11.80% | +3.77% | +26.05% | +71.35% | |
| Jazz Pharmaceuticals, Inc. | $9.995B | $227.8400 | -0.97% | +7.47% | +15.14% | +35.52% | +29.14% | |
| CRISPR Therapeutics AG | $5.209B | $52.8300 | -1.50% | +0.80% | +5.45% | +8.67% | +0.45% | |
| Beam Therapeutics Inc. Common Stock | $3.266B | $31.5800 | -1.76% | +5.55% | +15.75% | +16.39% | +16.99% | |
| Intellia Therapeutics, Inc | $2.015B | $13.9900 | +2.34% | +3.97% | +6.89% | +15.45% | +56.57% |
